Teva Pharma to sell more women's health assets for $1.38 billion: Reuters

Teva Pharmaceutical Industries Ltd (TEVA.N) (TEVA.TA) said on Monday it would sell the remaining assets in its specialty women’s health business for $1.38 billion in two separate transactions.

18 September 2017•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles